Download presentation
Presentation is loading. Please wait.
Published byΛέανδρος Φιλιππίδης Modified over 6 years ago
1
… a brain storming session … by Ladislav Šoltés
11/23/2018 High-dose ascorbate infusion makes cancer treatment more effective, trial shows … a brain storming session … by Ladislav Šoltés 11/23/2018 Medical News Today 3/31/2017
2
Cells standard standard
cancer cell noxa/noxae 11/23/2018 L. Šoltés
3
Solid tumors https://www. slideshare
11/23/2018 L. Šoltés
4
Solid tumors https://www. slideshare
11/23/2018 L. Šoltés
5
Solid tumors https://www. slideshare
11/23/2018 L. Šoltés
6
Solid tumors https://www. slideshare
11/23/2018 L. Šoltés
7
High-dose ascorbate infusion https://www. sciencedaily
Altered iron metabolism in cancer cells, and not normal cells, lead to increased sensitivity to cancer cell killing caused by high dose vitamin C The patients received three infusions of vitamin C a week for 2 months followed by two infusions per week for 7 months while receiving standard care radiation and chemotherapy. The goal of each infusion was to raise the concentration of vitamin C in a patient's blood to 20,000 μmol/l, as compared to a blood level of about 70 μmol/l found in most adults. The high dose is necessary because vitamin C has a half-life of about 2 hours in the circulation of humans. The tumor tissue contains high level of redox active iron molecules (a by-product of abnormal mitochondrial metabolism), which react with vitamin C to form H2O2 and free radicals derived from H2O2. These free radicals are believed to cause DNA damage selectively in cancer cells (vs. normal cells) leading to enhanced cancer cell death. 11/23/2018 L. Šoltés
8
Cells standard cancer 11/23/2018 L. Šoltés
9
Cells standard cancer Cancer cell death 11/23/2018 L. Šoltés
10
Cells standard cancer Otázky na autorov Cancer Cell 31 (2017) 487–500
? O ktorom „transitional metal“ ióne uvažujete v extracelulárnom priestore ? ? ? V intracelulárnom priestore sú prítomné aj ióny Cu2+ ! ? ? ? Viete o tom, že koncentrácia GSH v nádorových bunkách je omnoho vyššia ako v bunkách štandardných ? ? ? Produkcia H2O2 mitochondriami je zanedbateľná. Energiu nádorová bunka tvorí glykolýzou ! ? ? Je v cytosole nádorových buniek molekulový kyslík, alebo bunka je v podmienkach hypoxie ? Cancer Cell 31 (2017) 487–500 11/23/2018 L. Šoltés
11
Major biogenic elements (6)
11/23/2018 Major biogenic elements (6) Carbon (C) Hydrogen (H) Oxygen (O) Nitrogen (N) Sulfur (S) Phosphorus (P) Carbohydrates Lipids Proteins Enzymes DNA 3 4 5 6 11/23/2018 L. Šoltés
12
Cells standard cancer Koncentrácia GSH v cytosole !!!
! DNA je maximálne chránená pred poškodením Koncentrácia GSH v cytosole !!! Koncentrácia GSH v bunkách štandardných μmol/l, v nádorových >> μmol/l. 11/23/2018 L. Šoltés
13
Cells standard cancer To achieve the 20,000 μmol/l concentration of vitamin C in a patient's blood (5 liters in total) that means injection of “a bolus” of 17.6 g of vitamin C ! A slow infusion application means > > > > > 17.6 g !!! 11/23/2018 L. Šoltés
14
… a tissue … standard cancer
11/23/2018 L. Šoltés
15
… details of the cell surface … standard cancer
Extracellular fluid Carbohydrates: standard … 3% cancer … >>> 3% nm Cytosol 11/23/2018 11/23/2018 L. Šoltés L. Šoltés 15
16
Major biogenic elements (6)
11/23/2018 Major biogenic elements (6) Carbon (C) Hydrogen (H) Oxygen (O) Nitrogen (N) Sulfur (S) Phosphorus (P) Carbohydrates Lipids Proteins Enzymes DNA 3 4 5 6 11/23/2018 L. Šoltés
17
… details of the cell surface … standard cancer
Extracellular fluid Carbohydrates: standard … 3% cancer … >>> 3% nm Cytosol 11/23/2018 11/23/2018 L. Šoltés L. Šoltés 17
18
… Glycocalyx functions … standard
Has a negative electrical charge which attracts positively charged ions Protect cells against damages Serve to attach cells to one another Act as a part of the receptor sites Enter into immune reactions 11/23/2018 11/23/2018 L. Šoltés 18
19
of lower-molar-masses stimulates immunity responses
… Glycocalyx functions … cancer of lower-molar-masses stimulates immunity responses Immunogenic carbohydrates immunogenic 11/23/2018 11/23/2018 L. Šoltés 19
20
Cells standard cancer Otázky na autorov Cancer Cell 31 (2017) 487–500
? O ktorom „transitional metal“ ióne uvažujete v extracelulárnom priestore ? Manganese (Mn) , +7, +6, +4, +3 Iron (Fe) , +2, +5 , (+4), (+6) Cobalt (Co) , +3 , +4 Copper (Cu) , +1 Zinc (Zn) Vanadium (V) , +2, +3, +4 Molybdenum (Mo) , +2, +3, +4, +5 Nickel (Ni) , +3 ? Hadi S. M. et al., Chemotherapy 56 (2010) 280–284 “Catalytic Therapy of Cancer by Ascorbic Acid Involves Redox Cycling of Exogenous/Endogenous Copper Ions and Generation of Reactive Oxygen Species” 11/23/2018 L. Šoltés
21
Involvement of transition metals Fe Cu
11/23/2018 Involvement of transition metals Fe Cu [Fe(II)---complex] + O2 → [Fe(III)---complex] + O2.- 2O H+ → H2O2 + O dismutation reaction H2O2 + [Fe(II)---complex] → .OH + [Fe(III)---complex] + HO- Cu(I)---complex AscH- + 2[Fe(III)---complex] → H+ + 2[Fe(II)---complex] + DHA Dismutation reactions are usually very slow H2O2 + Cu(I)---complex → .OH + Cu(II) + [Fe(III)---complex] → H+ + [Fe(II)---complex] + t1/2 = 10-9 s; site specific .OH generation !!! + [Fe(III)---complex] → [Fe(II)---complex] + DHA Weissberger A. et al., Oxidation processes. XVI. The autoxidation of ascorbic acid. J Amer Chem Soc 1943, 65, 1934–1939 11/23/2018 L. Šoltés
22
Ergothioneine = (+)-charged thiol
Cu(I)---complex H2O2 + Cu(I)---complex → .OH + Cu(II) t1/2 = 10-9; site specific .OH generation !!! 11/23/2018 L. Šoltés
23
Reduction of cupric to cuprous ion by thiol
Motohashi N. et al., Complexing of cooper ion by ergothionenine. Chem Pharm Bull 1976, 24, 2364–2368 reduktívna chelatácia Cu(II) + ES- → Cu(I) + ½ ESSE Cu(I) + ES- → ES---Cu(I) __________________________________________ 1 Cu(II) + 2 ES- → ES---Cu(I) + ½ ESSE 11/23/2018 P. Rapta, K. Valachová, I. Valent, L. Šoltés
24
… Glycocalyx functions … cancer
Thiol application Cu(II) 11/23/2018 11/23/2018 L. Šoltés 24
25
… Glycocalyx functions … cancer
H2O2 action Cu(I) 11/23/2018 11/23/2018 L. Šoltés 25
26
… Glycocalyx functions … cancer
.OH 11/23/2018 11/23/2018 L. Šoltés 26
27
Hyaluronan (HA) fragmentation
11/23/2018 Hyaluronan (HA) fragmentation .OH + Initiation: HA + •OH → A• + H2O 11/23/2018 L. Šoltés
28
Hyaluronan fragmentation
11/23/2018 Hyaluronan fragmentation HA fragments → immuno-stimulatory 11/23/2018 L. Šoltés
29
of lower-molar-masses stimulates immunity responses
… Glycocalyx functions … cancer treatment of lower-molar-masses stimulates immunity responses Immunogenic carbohydrates immunogenic 11/23/2018 11/23/2018 L. Šoltés 29
30
… how to “demask” a tumor …
High-molar-mass hyaluronan solution with addition of Cu(II) ions Ascorbic acid was added 1 h later (black curve) 11/23/2018 K. Valachová
31
… how to “demask” a tumor …
High-molar/mass hyaluronan solution with addition of Cu(II) ions = time zero Ascorbic acid was added 1 h later (black curve) Ergothioneine applied = time zero [Cu(II):ergothioneine=1:2] Ascorbic acid was added 1 h later (yellow curve) 11/23/2018 K. Valachová
32
… how to “demask” a tumor …
High-molar/mass hyaluronan solution with addition of Cu(II) ions = time zero Ascorbic acid was added 1 h later (black curve) Ergothioneine applied = time zero [Cu(II):ergothioneine=1:2] Ascorbic acid was added 1 h later (yellow curve) High-molar/mass hyaluronan solution with addition of Cu(II) ions and ergothioneine = time zero ½ Ascorbic acid was added 1 h later (blue curve) 11/23/2018 K. Valachová
33
… Conclusions … .OH ... „treatment“ ... Is it based on targeting DNA by .OH ? Cancer Cell 31 (2017) 487–500 11/23/2018 L. Šoltés
34
… Conclusions … .OH ... „treatment“ ... Is it a demasking the cells by .OH ? Our TEAM: Hypotesis, speculation 11/23/2018 L. Šoltés et al.
35
… Conclusions … .OH ... „treatment“ ... Is it a demasking the cells by .OH ? ... „treatment“ ... Infusion of a thiol prior Asc- would potentiate the action of even lower ascorbate dose ? Our TEAM: Hypotesis, speculation 11/23/2018 L. Šoltés et al.
36
… Conclusions … 11/23/2018 L. Šoltés
37
… Conclusions … 11/23/2018 K. Valachová et al.
38
Nature 551, 37–38 2 November 2017 The surprising history of an antioxidant 11/23/2018 L. Šoltés
39
Acknowledgements 11/23/2018 11/23/2018 The TEAM 39 MA Jardine
LP Khonde 11/23/2018 11/23/2018 The TEAM 39
Similar presentations
© 2025 SlidePlayer.com Inc.
All rights reserved.